Publications
Publications

Teva Pharmaceutical Industries, Ltd.

By: Tarun Khanna and Krishna G. Palepu
  • Format:Video
ShareBar

Abstract

How do companies develop a strategy that is both low-cost and differentiated without becoming squeezed in the middle? Describes how Teva, Israel's largest and first multinational, achieved its globally dominant position in generic pharmaceuticals, an industry that has undergone significant change over the last 20 years. Examines Teva's strategies to defend itself against both low-cost competitors from India and other emerging markets as well as Big Pharma companies, which are adopting increasingly aggressive tactics in generics.

Keywords

Multinational Firms and Management; Emerging Markets; Rank and Position; Competitive Strategy; Pharmaceutical Industry; Israel; India

Citation

Khanna, Tarun, and Krishna G. Palepu. "Teva Pharmaceutical Industries, Ltd." Harvard Business School Video Supplement 708-806, November 2007.

About The Authors

Tarun Khanna

Strategy
More Publications

Krishna G. Palepu

Accounting and Management
More Publications

More from the Authors